Literature DB >> 9032330

Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin.

M Li1, H Lee, D W Yoon, J C Albrecht, B Fleckenstein, F Neipel, J U Jung.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) (also called human herpesvirus 8) is consistently found in Kaposi's sarcoma lesions and in body-cavity-based lymphomas. A 17-kb KSHV lambda clone was obtained directly from a Kaposi's sarcoma lesion. DNA sequence analysis of this clone identified an open reading frame which has 32% amino acid identity and 53% similarity to the virus-encoded cyclin (v-cyclin) of herpesvirus saimiri (HVS) and 31% identity and 53% similarity to human cellular cyclin D2. This KSHV open reading frame was shown to encode a 29- to 30-kDa protein with the properties of a v-cyclin. KSHV v-cyclin protein was found to associate predominantly with cdk6, a cellular cyclin-dependent kinase known to interact with cellular type D cyclins and HVS v-cyclin. The KSHV v-cyclin was also found to associate weakly with cdk4. KSHV v-cyclin-cdk6 complexes strongly phosphorylated glutathione S-transferase-Rb fusion protein and histone H1 as substrates in vitro. Thus, KSHV v-cyclin resembles the v-cyclin of the T-lymphocyte-transforming HVS in its specificity for association with cdk6 and in its ability to strongly activate cdk6 protein kinase activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032330      PMCID: PMC191282     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma.

Authors:  W Zhong; H Wang; B Herndier; D Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.

Authors:  Y Takebe; M Seiki; J Fujisawa; P Hoy; K Yokota; K Arai; M Yoshida; N Arai
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

Review 3.  AIDS. Viruses, cytokines and Kaposi's sarcoma.

Authors:  D Ganem
Journal:  Curr Biol       Date:  1995-05-01       Impact factor: 10.834

Review 4.  Inhibitors of mammalian G1 cyclin-dependent kinases.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

5.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

6.  Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization.

Authors:  R C Desrosiers; D P Silva; L M Waldron; N L Letvin
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

7.  Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4.

Authors:  L Stepanova; X Leng; S B Parker; J W Harper
Journal:  Genes Dev       Date:  1996-06-15       Impact factor: 11.361

8.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

9.  Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.

Authors:  D Whitby; M R Howard; M Tenant-Flowers; N S Brink; A Copas; C Boshoff; T Hatzioannou; F E Suggett; D M Aldam; A S Denton
Journal:  Lancet       Date:  1995-09-23       Impact factor: 79.321

10.  Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells.

Authors:  E A Mesri; E Cesarman; L Arvanitakis; S Rafii; M A Moore; D N Posnett; D M Knowles; A S Asch
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  100 in total

1.  Crystal structure of a gamma-herpesvirus cyclin-cdk complex.

Authors:  G L Card; P Knowles; H Laman; N Jones; N Q McDonald
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

2.  Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus.

Authors:  M Haque; J Chen; K Ueda; Y Mori; K Nakano; Y Hirata; S Kanamori; Y Uchiyama; R Inagi; T Okuno; K Yamanishi
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein.

Authors:  W Low; M Harries; H Ye; M Q Du; C Boshoff; M Collins
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  The murine gammaherpesvirus 68 v-cyclin gene is an oncogene that promotes cell cycle progression in primary lymphocytes.

Authors:  L F van Dyk; J L Hess; J D Katz; M Jacoby; S H Speck; I V Virgin HW
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 5.  Evolutionary aspects of oncogenic herpesviruses.

Authors:  J Nicholas
Journal:  Mol Pathol       Date:  2000-10

Review 6.  Herpesvirus homologues of cellular genes.

Authors:  M Raftery; A Müller; G Schönrich
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

7.  Murine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency.

Authors:  A T Hoge; S B Hendrickson; W H Burns
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  CAK-independent activation of CDK6 by a viral cyclin.

Authors:  P Kaldis; P M Ojala; L Tong; T P Mäkelä; M J Solomon
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

Review 9.  Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products.

Authors:  C Swanton; N Jones
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

10.  The role of cdc2 in the expression of herpes simplex virus genes.

Authors:  S J Advani; R R Weichselbaum; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.